{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:36:31Z","timestamp":1774305391179,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"China Nature Science Funds","award":["2011 81100300"],"award-info":[{"award-number":["2011 81100300"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.diabres.2013.12.006","type":"journal-article","created":{"date-parts":[[2013,12,25]],"date-time":"2013-12-25T15:45:50Z","timestamp":1387986350000},"page":"466-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Double-strand adeno-associated virus-mediated exendin-4 expression in salivary glands is efficient in a diabetic rat model"],"prefix":"10.1016","volume":"103","author":[{"given":"Junhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2013.12.006_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4093\/dmj.2011.35.4.317","article-title":"Polymeric gene delivery for diabetic treatment","volume":"35","author":"Kim","year":"2011","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2013.12.006_bib0010","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1074\/jbc.M209423200","article-title":"Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis","volume":"278","author":"Li","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabres.2013.12.006_bib0015","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/en.2010-0115","article-title":"Minireview: update on incretin biology: focus on glucagon-like peptide-1","volume":"151","author":"Brubaker","year":"2010","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2013.12.006_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1463-1326.2011.01457.x","article-title":"The future of incretin-based therapy: novel avenues\u2013novel targets","volume":"13","author":"Ahren","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2013.12.006_bib0025","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2009.06.002","article-title":"Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors","volume":"124","author":"Verspohl","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.beem.2009.03.008","article-title":"Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)\u2014preclinical and clinical results","volume":"23","author":"Madsbad","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2013.12.006_bib0035","doi-asserted-by":"crossref","first-page":"898913","DOI":"10.1155\/2011\/898913","article-title":"From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy","volume":"2011","author":"Dicembrini","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.diabres.2013.12.006_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcb.21819","article-title":"Adeno-associated virus-mediated gene transfer","volume":"105","author":"Srivastava","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.diabres.2013.12.006_bib0045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ymthe.2005.12.001","article-title":"Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors","volume":"13","author":"Stieger","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.diabres.2013.12.006_bib0055","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors","volume":"21","author":"Daya","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diabres.2013.12.006_bib0060","first-page":"240","article-title":"CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease","volume":"12","author":"Mandel","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0065","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2013.12.006_bib0070","first-page":"813","article-title":"NLX-P101, an adeno-associated virus gene therapy encoding glutamic acid decarboxylase, for the potential treatment of Parkinson's disease","volume":"11","author":"Diaz-Nido","year":"2010","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1016\/j.diabres.2013.12.006_bib0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/joe.1.06171","article-title":"Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders","volume":"185","author":"Voutetakis","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.gt.3300622","article-title":"Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands","volume":"5","author":"He","year":"1998","journal-title":"Gene Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/hum.2010.097","article-title":"Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer","volume":"22","author":"Adriaansen","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0095","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.bbadis.2011.06.014","article-title":"Gene delivery in salivary glands: from the bench to the clinic","volume":"1812","author":"Samuni","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.diabres.2013.12.006_bib0100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.diabres.2013.12.006_bib0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol Res"},{"key":"10.1016\/j.diabres.2013.12.006_bib0115","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/BF03347560","article-title":"Glucagon-like peptide 1 (GLP-1) and metabolic diseases","volume":"28","author":"Rotella","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.diabres.2013.12.006_bib0120","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1530\/EJE-09-0101","article-title":"Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"160","author":"Monami","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/vhrm.2006.2.1.69","article-title":"Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes","volume":"2","author":"Schnabel","year":"2006","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.diabres.2013.12.006_bib0130","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/endo.141.6.7490","article-title":"Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats","volume":"141","author":"Szayna","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2013.12.006_bib0225","first-page":"260","article-title":"NT4 a NAP prokaryotic expression vector construction and in escherichia coli expression","volume":"37","author":"Yu","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0140","first-page":"1","article-title":"Biology of adeno-associated virus","volume":"218","author":"Berns","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000024980","article-title":"Delayed expression of adeno-associated virus vector DNA","volume":"42","author":"Afione","year":"1999","journal-title":"Intervirology"},{"key":"10.1016\/j.diabres.2013.12.006_bib0150","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/jvi.70.5.3227-3234.1996","article-title":"Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors","volume":"70","author":"Ferrari","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0155","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0160","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","article-title":"Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors","volume":"78","author":"Thomas","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0165","doi-asserted-by":"crossref","first-page":"e40074","DOI":"10.1371\/journal.pone.0040074","article-title":"Sustained exendin-4 secretion through gene therapy targeting salivary glands in two different rodent models of obesity\/type 2 diabetes","volume":"7","author":"Di Pasquale","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2013.12.006_bib0170","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1089\/hum.1996.7.17-2177","article-title":"Evidence for the systemic delivery of a transgene product from salivary glands","volume":"7","author":"Kagami","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0175","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1089\/10430349950016528","article-title":"Polarized secretion of transgene products from salivary glands in vivo","volume":"10","author":"Baum","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.diabres.2013.12.006_bib0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0074-7696(02)13013-0","article-title":"Gene transfer to salivary glands","volume":"213","author":"Baum","year":"2002","journal-title":"Int Rev Cytol"},{"key":"10.1016\/j.diabres.2013.12.006_bib0185","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1034\/j.1600-0714.2003.t01-1-00004.x","article-title":"Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats","volume":"32","author":"O\u2019Connell","year":"2003","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.diabres.2013.12.006_bib0190","doi-asserted-by":"crossref","first-page":"e59222","DOI":"10.1371\/journal.pone.0059222","article-title":"Expression and secretion of human proinsulin-b10 from mouse salivary glands: implications for the treatment of type I diabetes mellitus","volume":"8","author":"Rowzee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2013.12.006_bib0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1601-0825.2011.01885.x","article-title":"TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice","volume":"18","author":"Vosters","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.diabres.2013.12.006_bib0200","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.diabres.2013.12.006_bib0205","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc06-2375","article-title":"Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes","volume":"30","author":"Kim","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.12.006_bib0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5483\/BMBRep.2010.43.2.146","article-title":"Induction of insulin receptor substrate-2 expression by Fc fusion to exendin-4 overexpressed in E. coli: a potential long-acting glucagon-like peptide-1 mimetic","volume":"43","author":"Kim","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.diabres.2013.12.006_bib0215","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/psc.942","article-title":"Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris","volume":"14","author":"Huang","year":"2008","journal-title":"J Pept Sci"},{"key":"10.1016\/j.diabres.2013.12.006_bib0220","doi-asserted-by":"crossref","first-page":"e6221","DOI":"10.1371\/journal.pone.0006221","article-title":"Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells","volume":"4","author":"Peyot","year":"2009","journal-title":"PLoS One"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:05:29Z","timestamp":1759172729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822713004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0168822713004397"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2013.12.006","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Double-strand adeno-associated virus-mediated exendin-4 expression in salivary glands is efficient in a diabetic rat model","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2013.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}